Partners
Affectis creates alliances to complement its own expertise and ensure optimum progress with its in-house programs.
Affectis creates alliances to complement its own expertise and ensure optimum progress with its in-house programs.
In the areas of drug discovery, chemistry, preclinical and clinical services the company has entered into service agreements with GVK Biosciences Ltd. (India), LAB Research Inc. (Canada) and Dalton Pharma Services Inc. (Canada), and FGK Clinical Research GmbH (Germany). Research collaborations are ongoing with the Max Planck-Institute of Psychiatry, Munich, and the University of Laval in Quebec, Canada.
Furthermore, Affectis evaluates co-development partnerships with the pharmaceutical industry that cover all aspects of the drug development chain, including commercialisation. Affectis’ expertise has already attracted high-profile companies like Novartis, Amarin, Organon and Mitsubishi Pharma for research agreements.